-transparent.png){kind=logo}
Endothelium-derived relaxing factor (EDRF) and donors of nitric oxide (NO) (glyceryl trinitrate, SIN-1--a metabolite of molsidomine--S-nitroso-N-acetyl-penicillamine, and sodium nitroprusside) but not prostacyclin and its analog, iloprost, relax strips of rabbit aorta. Strips of human coronary artery also relax when exposed to NO donors and prostacyclin; in this artery, SIN-1 and iloprost exert additive but not synergistic relaxant action. In mildly activated human platelets and leukocytes, SIN-1 and iloprost have a synergistic suppressive action. A similar synergistic thrombolytic effect between NO and prostacyclin was observed in whole rabbit blood in interactions with rabbit aortic endothelium. These findings suggest that because of this cell-selective synergism between NO donors and prostacyclin analogs, the concomitant use of molsidomine and iloprost for the treatment of ischemic heart and peripheral vascular disease should be attempted.
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
October 1993,
Sheng li ke xue jin zhan [Progress in physiology],
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
May 1994,
The American journal of physiology,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
January 1991,
European journal of clinical pharmacology,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
January 1994,
Seminars in thrombosis and hemostasis,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
March 1993,
Journal of cardiovascular pharmacology,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
May 2000,
Atherosclerosis,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
August 1981,
Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
February 1997,
Prostaglandins, leukotrienes, and essential fatty acids,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
December 1989,
British journal of pharmacology,
R J Gryglewski, and
R Korbut, and
E Trabka-Janik, and
A Zembowicz, and
M Trybulec
October 1988,
Journal of molecular and cellular cardiology,
